Profile 5: Pediatric and Adolescent Patients Under 18 Wegovy received FDA approval for chronic weight management in adolescents aged 12 and older in December 2022, based on the STEP TEENS trial (N=201, semaglutide 2.4 mg weekly, 68 weeks, mean BMI reduction of 16.1% vs
The other dangers are too big
People take glutathione tablets for everyday wellness, traveling, high altitudes, jet lag, post-workout recovery, anti-aging reasons, liver detox, and the morning after drinks
MA: Writing original draft, Writing review and editing
Figure 5 The maximum stimulated C-peptide was not different in patients on GLP-1 agonists and placebo (40, 46, 48, 49), MD=-0.75, 95% CI , - 2.17-0.66